Sustained monomorphic ventricular tachycardia after adenosine infusion.
Adenosine is used as pharmacological treatment of the first choice for the termination of regular small complex tachycardia. Although it is considered safe in this context, several reports of short lasting proarrythmic effects have been described. We present a case of a sustained monomorphic ventricular tachycardia following adenosine infusion.
Huemer
Martin
M
Boldt
Leif-Hendrik
LH
Rolf
Sascha
S
Blaschke
Daniela
D
Parwani
Abdul
A
Haverkamp
Wilhelm
W
D000241:Adenosine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D007275:Injections, Intravenous; D013610:Tachycardia / Q000175:diagnosis / Q000188:drug therapy*; D017180:Tachycardia, Ventricular / Q000139:chemically induced* / Q000503:physiopathology*; D018879:Ventricular Premature Complexes / Q000139:chemically induced / Q000175:diagnosis
D000889:Anti-Arrhythmia Agents; D000241:Adenosine